Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.04 USD | +1.12% | -6.05% | -29.68% |
13/05 | HC Wainwright Adjusts Price Target on Verona Pharma to $30 From $32, Maintains Buy Rating | MT |
09/05 | Verona Pharma Signs Financing Agreements for Up to $650 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.68% | 1.12B | |
+5.99% | 111B | |
+11.58% | 106B | |
-12.67% | 22.24B | |
+0.12% | 21.25B | |
-5.06% | 18.97B | |
-35.21% | 18.52B | |
-11.45% | 16.81B | |
+38.07% | 12.54B | |
-24.65% | 8.09B |
- Stock Market
- Equities
- VRNA Stock
- News Verona Pharma plc
- HC Wainwright Adjusts Verona Pharma's Price Target to $32 From $30, Keeps Buy Rating